Charles J Link Jr
Inventor
Stats
- 0 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 10 US Applications Filed
- 111 Total Citation Count
- Sep 19, 2006 Most Recent Filing
- Aug 19, 2003 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CENTRAL IOWA HEALTH SYSTEM | 1
| 2006
|
NORTHWESTERN UNIVERSITY | 1
| 2005
|
NEWLINK GENETICS CORPORATION | 2
| 2004
|
Iowa Health System | 2
1 | 2003
2004 |
NEWLINK GENETICS | 1
| 2005
|
Newlinks Genetics Corporation | 1
| 2004
|
Human Gene Therapy Research Institute | 2
| 2005
|
Inventor Addresses
Address | Duration |
---|---|
Ames, IA | Jul 01, 04 - Oct 06, 05 |
Ames, IA, US | Nov 10, 05 - Nov 10, 05 |
CLIVE, IA | Jan 18, 07 - Jan 18, 07 |
Clive, IA | Sep 30, 04 - Feb 16, 06 |
Des Moines, IA | Sep 30, 04 - Sep 30, 04 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
C07K: | PEPTIDES | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2007/0014,775 | 2007 | ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE | 10 |
2007/0014,774 | 2007 | ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE | 5 |
2006/0034,812 | 2006 | Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect | 1 |
2005/0266,544 | 2005 | Methods and compositions for increasing viral vector production in packaging cell lines | 1 |
2005/0250,107 | 2005 | Selectable gene marker system based on expression of N-acetyllactosaminide 3-alpha galactosyltransferase | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.